Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.
Press releases published on August 26, 2025
Advanced Fat Burners for Men & Women for belly Fat 2025: Wolfson Brands Launch “ Safest weight-loss supplement in USA.
GlobeNewswire
·
August 26, 2025
new York, Aug. 26, 2025 (GLOBE NEWSWIRE) -- New York, Aug. 22, 2025 Wolfson Brands has introduced an upgraded collection of fat-burning supplements. The leading health and wellness experts today unveiled their list of Best Fat Burners for Men and Women, …
University of St. Augustine for Health Sciences Sponsors U.S. Open Adaptive Surfing Championships for Fifth Consecutive Year
GlobeNewswire
·
August 26, 2025
OCEANSIDE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The University of St. Augustine for Health Sciences (USAHS) is proud to announce its continued role as the title sponsor for the 8th Annual U.S. Open Adaptive Surfing Championships, taking place …
Circurna Engages GATC Health for AI-Powered Discovery to Accelerate ciRNA™ Circular RNA Therapeutics
GlobeNewswire
·
August 26, 2025
HOUSTON and IRVINE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Circurna, (www.circurna.com) a biotechnology company advancing its proprietary ciRNA™ circular RNA platform, and GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) …
Patient-Led Decisions Accelerate IBD Treatment Switching, Spherix Global Insights Finds
GlobeNewswire
·
August 26, 2025
EXTON, PA, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Patients with inflammatory bowel disease (IBD) in the US are taking a more active role than ever before in the decision to switch their advanced therapies, driving faster transitions between treatments and …
Traliant Introduces New Fraud, Waste and Abuse in Healthcare Training to Protect Organizations from Costly Violations
GlobeNewswire
·
August 26, 2025
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Traliant, a leader in online compliance training, today announced its new course, Fraud, Waste and Abuse in Healthcare, designed to help healthcare organizations that accept public funds prevent costly violations …
FAMU College of Pharmacy Alumnus and Industry Pioneer Stan Loomis Inducted into Gallery of Distinction and Keynoted the 2025 White Coat Ceremony
GlobeNewswire
·
August 26, 2025
ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals, two of the nation's leading compound pharmacies, announce today that co-founder Stan Loomis was inducted into the Florida A…
Dr. Shai Efrati Honored With 2025 Ellis Island Medal of Honor
GlobeNewswire
·
August 26, 2025
THE VILLAGES, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Ellis Island Honors Society has recognized Dr. Shai Efrati as a 2025 Ellis Island Medal of Honor recipient, celebrating his pioneering contributions to hyperbaric oxygen therapy and years of service …
PolarityBio Completes Enrollment in the Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers
GlobeNewswire
·
August 26, 2025
SALT LAKE CITY, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PolarityBio, a clinical-stage biotechnology company focused on addressing unmet needs in wound healing through innovation in autologous regenerative skin multicellular therapy, today announced the …
Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
GlobeNewswire
·
August 26, 2025
LAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY) (the “Company” or “Odyssey”), a technology and asset acquisition company focused on developing unique, life-saving medical products is pleased to provide the following update …
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
GlobeNewswire
·
August 26, 2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 26, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announces that it has successfully identified a new biological target and novel therapeutic indication for its lead …
Adagene to Participate in Two Investor Conferences in September
GlobeNewswire
·
August 26, 2025
SAN DIEGO and SUZHOU, China, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chief Strategy …
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
GlobeNewswire
·
August 26, 2025
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX Trial Designs in Wet AMD and Diabetic Retinopathy to be Featured in Presentation by Dr. Sobha Sivaprasad - …
Proxygen and EPFL Launch Strategic Collaboration to Advance AI-Driven Glue Discovery
GlobeNewswire
·
August 26, 2025
VIENNA and LAUSANNE, Switzerland, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Proxygen, a global leader in the discovery and development of molecular glue degraders, today announced a strategic research collaboration with EPFL (the Swiss Federal Institute of …
Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer
GlobeNewswire
·
August 26, 2025
TARPON SPRINGS, Fla., August 26, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor …
Nasus Pharma Marks NYSE American Listing with Bell Ringing Ceremony
GlobeNewswire
·
August 26, 2025
TEL AVIV, Israel, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions …
Compass Therapeutics to Participate in Upcoming September Investor Events
GlobeNewswire
·
August 26, 2025
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today …
Fulcrum Therapeutics to Present at Upcoming Investor Meetings
GlobeNewswire
·
August 26, 2025
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Ashvattha Therapeutics to Present Late-Breaking Phase 2 DME and nAMD Data at 25th EURETINA Congress
GlobeNewswire
·
August 26, 2025
Company to present topline 40-week Phase 2 study efficacy and safety results of migaldendranib (MGB), a novel first-in-class nanomedicine for DME and nAMD Subcutaneous at-home administration represents a potential paradigm shift from frequent in-office …
PharmaTher Provides Corporate Update Following FDA Approval of Ketamine (KETARx™)
GlobeNewswire
·
August 26, 2025
TORONTO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to provide a …
Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR’ Platform
GlobeNewswire
·
August 26, 2025
– Unlocks exciting new AI-driven brain biomarker discovery and advancement capabilities – – Substantial processing speed gains while maintaining high signal quality standards – – Comes just months after Firefly announced its acceptance into the NVIDIA …